Crossmark

The efficacy of tofacitinib combined with bDMARDs in the treatment of ankylosing spondylitis patients with inadequate response to bDMARDs: a retrospective study

Crossref DOI link: https://doi.org/10.1186/s41927-024-00373-y

Published Online: 2024-01-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chang, Jie

Wang, Gang
License Information

Text and Data Mining valid from 2024-01-25

Version of Record valid from 2024-01-25
More Information

Article History

Received: 18 July 2023

Accepted: 11 January 2024

First Online: 25 January 2024

Declarations

:

: This retrospective study was approved by the ethics Committee of the Fourth Affiliated Hospital, Zhejiang University School of Medicine. We confirm that all methods were performed in accordance with the relevant guidelines and regulations. Written informed consent was obtained from all enrolled patients.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below